Cargando…
The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study
PURPOSE: Several genomic tests have recently been developed to identify the primary tumour in cancer of unknown primary tumour (CUP). However, the value of identifying the primary tumour in clinical practice for CUP patients remains questionable and difficult to prove in randomized trials. OBJECTIVE...
Autores principales: | Hannouf, Malek B., Winquist, Eric, Mahmud, Salaheddin M., Brackstone, Muriel, Sarma, Sisira, Rodrigues, George, Rogan, Peter K., Hoch, Jeffrey S., Zaric, Gregory S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103931/ https://www.ncbi.nlm.nih.gov/pubmed/29623630 http://dx.doi.org/10.1007/s41669-017-0051-2 |
Ejemplares similares
-
The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort Study
por: Hannouf, Malek B., et al.
Publicado: (2018) -
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer
por: Hannouf, Malek B, et al.
Publicado: (2012) -
Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer
por: Hannouf, Malek B., et al.
Publicado: (2012) -
Tumour dormancy in breast cancer: an update
por: Brackstone, Muriel, et al.
Publicado: (2007) -
Financial Incentives and Cervical Cancer Screening Participation in Ontario's Primary Care Practice Models
por: Pendrith, Ciara, et al.
Publicado: (2016)